Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension

Shanshan Zhang(Central South University), Christine G. Schnackenberg(GlaxoSmithKline (United States)), Andrew P. Mayer(GlaxoSmithKline (United States)), Casey Kmett(Providence College), J. S. Mason(Age UK), Yixuan Wu(Rapt Therapeutics (United States)), Abby Whitnall(Age UK), Patrick Koenig(Rapt Therapeutics (United States)), Sapna Desai(Age UK), Joseph Foley, Nicholas P. Barton(Age UK), Jonathan Kehler(South College), Jessie J. Polanco(Rapt Therapeutics (United States)), Xin Wang(23andMe (United States)), Davide Foletti(Rapt Therapeutics (United States)), Heather P. O’Keefe(South College), Steven J. Pitts, Jonathan Davitte(GlaxoSmithKline (United States)), Caitlin Vestal Tibbetts, Audrey E. Tolbert, Gabriela Kozejova(Age UK), Karen Amaratunga(Age UK), Feng Wang(First Affiliated Hospital of Bengbu Medical College), Andrew H. Chang(Stanford University), Lisa C. Sloan(National Oceanic and Atmospheric Administration), Audrey Y. Chu(University of Helsinki), Nazia Parvez(Age UK), Adam Csakai(University of Colorado Boulder), A Hartman(South College), Lance Larrabee(Rapt Therapeutics (United States))
Scientific Reports
March 4, 2025
Cited by 0


Related Papers